Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease
about
Identification of potential pathway mediation targets in Toll-like receptor signalingA network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.Diabetes is a proinflammatory state: a translational perspective.The inflammatory response to double stranded DNA in endothelial cells is mediated by NFκB and TNFαSystemic endotoxin levels in chronic indolent periodontal infections.Egg intake during carbohydrate restriction alters peripheral blood mononuclear cell inflammation and cholesterol homeostasis in metabolic syndrome.Synthetic Toll like receptor-4 (TLR-4) agonist peptides as a novel class of adjuvantsFormal modelling of toll like receptor 4 and JAK/STAT signalling pathways: insight into the roles of SOCS-1, interferon-β and proinflammatory cytokines in sepsisPrevention of endotoxin-induced uveitis in rats by benfotiamine, a lipophilic analogue of vitamin B1CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.Recurrent exposure to subclinical lipopolysaccharide increases mortality and induces cardiac fibrosis in mice.Innate immune programing by endotoxin and its pathological consequencesIcariin and its derivative, ICT, exert anti-inflammatory, anti-tumor effects, and modulate myeloid derived suppressive cells (MDSCs) functions.Periodontal CD14 mRNA expression is downregulated in patients with chronic periodontitis and type 2 diabetes.Erlotinib protects against LPS-induced endotoxicity because TLR4 needs EGFR to signal.Do statins improve outcomes in patients with asthma on inhaled corticosteroid therapy? A retrospective cohort analysisGene expression profiling of peripheral blood mononuclear cells in the setting of peripheral arterial disease.Anti-inflammatory trends of new benzimidazole derivatives.Toll-like Receptors in the Vascular System: Sensing the Dangers Within.Increased toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state.The effect of prebiotic supplementation with inulin on cardiometabolic health: Rationale, design, and methods of a controlled feeding efficacy trial in adults at risk of type 2 diabetes.Ubiquitin-specific Protease 20 Regulates the Reciprocal Functions of β-Arrestin2 in Toll-like Receptor 4-promoted Nuclear Factor κB (NFκB) Activation.Discovery and development of toll-like receptor 4 (TLR4) antagonists: a new paradigm for treating sepsis and other diseases.Toll-like receptors, transduction-effector pathways, and disease diversity: evidence of an immunobiological paradigm explaining all human illness?Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice.Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions.Phenylmethimazole decreases Toll-like receptor 3 and noncanonical Wnt5a expression in pancreatic cancer and melanoma together with tumor cell growth and migration.Toll-like receptors and diabetes: a therapeutic perspective.Structure, function and disease relevance of Omega-class glutathione transferases.Escherichia coli Nissle 1917 protects gnotobiotic pigs against human rotavirus by modulating pDC and NK-cell responses.Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6.Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo.Atorvastatin inhibits the immediate-early response gene EGR1 and improves the functional profile of CD4+T-lymphocytes in acute coronary syndromes.A purified capsular polysaccharide markedly inhibits inflammatory response during endotoxic shock.Studies of synthetic chalcone derivatives as potential inhibitors of secretory phospholipase A2, cyclooxygenases, lipoxygenase and pro-inflammatory cytokines.Citreoviridin enhances tumor necrosis factor-α-induced adhesion of human umbilical vein endothelial cells.Toll-like receptor activity in patients with obstructive sleep apnea.Neonatal Lipopolysaccharide Exposure Gender-Dependently Increases Heart Susceptibility to Ischemia/Reperfusion Injury in Male Rats.Homeostatic role of Toll-like receptor 4 in the endothelium and heart.Prenatal exposure to lipopolysaccharide results in increases in blood pressure and body weight in rats.
P2860
Q28474725-EA1891CF-8309-49B4-814C-613DAD43A378Q30841144-1821E4DA-E3A6-4CDA-B2F1-4F2C7FCC234AQ33693974-2392707C-CE9E-474B-AC2C-5B47CC32C5F6Q33911092-0F3563B6-8658-43B2-B7AE-5FB4F9BEC4F5Q33917860-CF582723-4110-4C06-9C2D-4A4FA894FB19Q33963273-14EA6F18-BCDB-4AAC-A85B-D248718F0615Q34170285-74129E70-DD2A-4F5A-B994-84304106386DQ34290672-CA0DEF2A-A630-4A7C-BDE2-7277BD322F45Q34602979-5B40BDF0-D63B-4989-9A91-BA2A537864BFQ34657057-ACD5DFF6-5C65-43F7-AF33-22C5B119067DQ34667902-B99C63E3-4B4D-49FE-A1D9-900572BE87DDQ34841012-E71014E8-FBBC-404A-BBAD-6B9074D35FFAQ35028415-BA75B510-6CD7-4198-B1EB-2E7D2630C0C9Q35845658-2C12CD67-BFAB-4583-93B8-30085A58A3FBQ35946356-82E248D5-DF29-4A51-9232-C6FFC6B448ECQ35999292-F0DE3991-72C4-4897-B76E-62928265AF4CQ36054090-6F60D05F-9E3C-4E5B-814B-1A1E5F7B6360Q36139722-E5FF04BC-5A4E-4591-98E7-022ABFCA543BQ36453194-2D168B33-7D00-4550-A85B-A7FE812B009DQ36459935-739E0D1C-1BFC-4326-A714-659305033745Q36551843-EEF5CF20-B2D0-49B0-903A-229CD2139AD6Q36755025-1769C3EC-3BD8-496E-BA63-AFF3A9A53845Q37169130-A066E0F4-8E2A-4FC6-AB5E-609B98F2779EQ37198685-15912691-5906-43C2-B90D-B17B7ADE9B5BQ37281187-29A9796E-B259-4E31-B233-4B72E853B69AQ37373876-341F65A3-5ED5-4ADB-8EA2-E24C990D18CAQ37394701-068B89F0-7874-4C3F-A322-9187CE57E8B9Q37954396-CFD22915-DF2C-49E0-9542-BAA4B3A5B6FFQ38780816-03BE5106-3D31-4649-83F2-BE325B3AD9BCQ40600252-5A759730-D100-481D-BF8B-B1A60F4ABBDCQ41941165-5515D9C7-46B0-4625-BFB7-5865B120EEFCQ41969861-8AD5F704-03A6-4E5A-B28C-05FB78D32DC4Q42005918-9F32ED31-2A93-4FFB-B873-67996481438EQ42530714-B0CF1006-0DC1-4B7A-98CD-03767C9CF76CQ42910608-F005E041-9E9C-47ED-8013-4AB71C0EACE2Q44778714-D36664AB-8ABE-4DF9-B56E-D663BC6D3FCBQ45323315-A264FB65-6E03-4D5D-ADD2-6CBAA8189F3FQ46571495-22997166-77B8-45A5-8308-6C4841416066Q46825546-FE45553D-DD20-4953-8801-CC82C743EB67Q47292368-F20F7D56-0D34-4262-92DA-A760D73AAF82
P2860
Endotoxin, TLR4 signaling and vascular inflammation: potential therapeutic targets in cardiovascular disease
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@ast
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@en
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@nl
type
label
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@ast
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@en
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@nl
prefLabel
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@ast
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@en
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@nl
P2093
P921
P1476
Endotoxin, TLR4 signaling and ...... gets in cardiovascular disease
@en
P2093
Gerene M Denning
Lynn L Stoll
Neal L Weintraub
P304
P356
10.2174/138161206778743501
P407
P577
2006-01-01T00:00:00Z